Skip to main content

Table 2 Mean (SD) values of Multiple Sclerosis Self-Efficacy Scale (MSSES) and Impact on Participation and Autonomy (IPA) scores at 1, 3 and 6 months after SCDP in the total group and in the Relapsing Remitting (RR) and Progressive (P) subgroups

From: Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study

  Baseline 1 month 3 months 6 months
  Total RR P Total RR P Total RR P Total RR P
MSSES-Function 66.45 (21.52) 81.80 (12.15) 53.59 (19.62) 66.28 (21.29) 81.70 (12.52) 54.09 (19.31) 64.47 (22.41) 74.75 (19.33) 54.23 (20.28) 66.10 (21.93) 81.30 (12.00) 50.94 (18.07)
MSSES-Control 47.79 (19.06) 57.01 (19.67) 41.63 (15.29) 49.33 (17.42) 58.04 (15.01) 43.84 (16.24) 49.64 (19.76) 53.52 (18.28) 45.50 (20.77) 55.05 (18.91) 64.26 (13.66) 46.18 (19.44)
IPA-Limitations 2.70 (0.57) 2.43 (0.57) 2.89 (0.50) 2.59 (0.63) 2.34 (0.53) 2.76 (0.65) 2.57 (0.62) 2.26 (0.51) 2.85 (0.56) 2.58 (0.67) 2.30 (0.55) 2.88 (0.64)
IPA-Problems 2.09 (0.36) 1.95 (0.36) 2.17 (0.32) 1.97 (0.46) 1.73 (0.39) 2.11 (0.43) 1.93 (0.52) 1.74 (0.48) 2.07 (0.54) 2.02 (0.51) 1.86 (0.52) 2.14 (0.48)